Tesla And Michigan Reach Settlement For Direct Delivery To Customers
Electric vehicles maker Tesla Inc. (NASDAQ:TSLA) has reached a settlement with the state of Michigan in a 2016…
EC Approves Roche’s Polivy for People with Previously Treated Aggressive Lymphoma
Roche (OTC:RHHBY) today announced that the European Commission has granted conditional marketing authorisation for Polivy® (polatuzumab vedotin), in…
60 Biggest Movers From Friday
Gainers iMedia Brands, Inc. (NASDAQ:IMBI) shares surged 42.2% to close at $4.48 on Friday after the company reported…
7 Stocks To Watch For January 21, 2020
Some of the stocks that may grab investor focus today are: Wall Street expects Halliburton Company (NYSE:HAL) to…
Tesla Says Petition Claiming ‘Unintended Acceleration’ In Cars Brought By ‘Tesla Short-Seller’
Tesla Inc. (NASDAQ:TSLA) on Monday responded to a petition filed with the National Highway Traffic Safety Administration last…
Earnings Scheduled For January 21, 2020
Companies Reporting Before The Bell Halliburton Company (NYSE:HAL) is projected to report quarterly earnings at $0.29 per share…
Samsung Names New Smartphone Chief As It Seeks To Secure Market Dominance
Samsung Electronics Co. Ltd. (OTC:SSNLF) has promoted its youngest president Roh Tae-moon to lead the smartphone unit, Bloomberg…
Novartis Announces EU Approval of Mayzent for Adult Patients with Secondary Progressive MS with Active Disease
Novartis (NYSE:NVS) today announced the European Commission (EC) has approved Mayzent® (siponimod) for the treatment of adult patients…
Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced that the European Commission approved Sunosi® (solriamfetol) to improve wakefulness and reduce…
Genmab Announces EU Marketing Authorization for DARZALEX in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
Genmab A/S (NASDAQ:GMAB) announced today that the European Commission (EC) has granted marketing authorization for DARZALEX® (daratumumab) in…